However, FSTL1 remains to be further investigated as a promising clinical biomarker for renal tubulointerstitial injury in DN.The ssGSEA analysis indicate that the dysregulated expression of selective genes is associated with the pathological and physiological effects of DN. Here, FSTL1 is linked to liver dysplastic nodule.